Frazier Management

Frazier Management as of Sept. 30, 2020

Portfolio Holdings for Frazier Management

Frazier Management holds 31 positions in its portfolio as reported in the September 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Arcutis Biotherapeutics (ARQT) 27.7 $309M 11M 29.30
Phathom Pharmaceuticals (PHAT) 19.2 $214M 5.8M 36.67
Vaxcyte (PCVX) 10.2 $114M 2.3M 49.38
Mirum Pharmaceuticals (MIRM) 6.2 $69M 3.6M 19.27
Passage Bio 5.9 $66M 5.0M 13.11
Iovance Biotherapeutics (IOVA) 3.9 $43M 1.3M 32.92
Trillium Therapeutics Com New 3.6 $40M 2.8M 14.19
Krystal Biotech (KRYS) 3.5 $39M 895k 43.05
Anaptysbio Inc Common (ANAB) 3.1 $34M 2.3M 14.75
Translate Bio 2.7 $30M 2.2M 13.61
Alpine Immune Sciences 2.0 $23M 2.6M 8.79
Collegium Pharmaceutical Inc Common Stock Usd (COLL) 1.8 $20M 944k 20.82
Syndax Pharmaceuticals (SNDX) 1.7 $20M 1.3M 14.76
Adverum Biotechnologies 1.3 $15M 1.4M 10.30
Iveric Bio 1.2 $13M 2.4M 5.64
Rocket Pharmaceuticals (RCKT) 1.1 $12M 528k 22.86
Aptinyx 1.0 $11M 3.2M 3.38
Freeline Therapeutics Hldgs Sponsored Ads 0.8 $8.6M 550k 15.61
Gritstone Oncology Ord (GRTSQ) 0.5 $5.5M 2.1M 2.65
Allena Pharmaceuticals 0.4 $4.9M 3.3M 1.48
Regenxbio Inc equity us cm (RGNX) 0.4 $4.8M 174k 27.52
Cidara Therapeutics Inc Common Stock Usd 0.0001 0.3 $3.7M 1.3M 2.85
Cardiff Oncology (CRDF) 0.3 $3.7M 260k 14.19
Bellus Health Com New 0.3 $3.0M 1.3M 2.28
Nabriva Therapeutics SHS 0.2 $2.3M 4.3M 0.53
Sierra Oncology Com New 0.2 $2.2M 203k 10.67
Vtv Therapeutics Cl A 0.2 $1.9M 1.1M 1.77
Minerva Neurosciences 0.2 $1.7M 550k 3.18
Iterum Therapeutics SHS 0.1 $1.6M 1.5M 1.05
Bellicum Pharmaceuticals Com New 0.1 $691k 105k 6.57
Entasis Therapeutics Holdings Ord 0.0 $408k 200k 2.04